This week, the practice of granting patents on portions of the human genome came under a full-bore legal assault when groups representing more than 100,000 doctors and researchers, along with the Public Patent Foundation and the ACLU, filed suit against the PTO and a genetic testing company. The suit's main goal is to invalidate seven patents giving sole rights to test and do research on a pair of genes closely connected to breast and ovarian cancer. The larger goal is "to take down patents on human genes."
Lawsuit Looks to 'Take Down' Patents on Human Genes
IP Law & Business
May 15, 2009